Skip to content

Drug interactions

Eslicarbazepine + Tofacitinib

Severity: Minor

Eslicarbazepine and Tofacitinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine has weak CYP3A4 induction and weak CYP2C19 inhibition, which have opposing effects on tofacitinib exposure. The net effect is likely small and unpredictable.

What this interaction means in plain words

Eslicarbazepine and Tofacitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Eslicarbazepine belongs to Central Nervous System; Tofacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Weak CYP3A4 induction and weak CYP2C19 inhibition by eslicarbazepine act in opposite directions.

What to do

No empirical dose change; monitor therapeutic response and adverse effects of tofacitinib.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eslicarbazepine with Tofacitinib?

MediHelp rates the interaction as minor. Eslicarbazepine and Tofacitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eslicarbazepine has weak CYP3A4 induction and weak CYP2C19 inhibition, which have opposing effects on tofacitinib exposure. The net effect is likely small and unpredictable.

How serious is the interaction between Eslicarbazepine and Tofacitinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change; monitor therapeutic response and adverse effects of tofacitinib.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in